Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Boehringer Ingelheim
Express Scripts
AstraZeneca
Johnson and Johnson

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp. (D. Del. 2016)

See Plans and Pricing

« Back to Dashboard

Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-09-16
Court District Court, D. Delaware Date Terminated 2018-10-29
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To Mary Pat Thynge
Parties MERCK SHARP & DOHME CORP.; SANOFI WINTHROP INDUSTRIE; SANOFI-AVENTIS DEUTSCHLAND GMBH; SANOFI-AVENTIS U.S. LLC
Patents 7,476,652; 7,713,930; 7,918,833; 8,512,297; 8,556,864; 8,603,044; 8,679,069; 8,992,486; 9,011,391; 9,233,211; 9,526,844; 9,533,105; 9,604,008
Attorneys Ahmed J. Davis; Alex T. Potter; Amanda K. Antons; AnnaMartina Tyreus Hufnal; Arthur G. Connolly , III; Bill Ward; Brian D. Coggio; Brian P. Biddinger; Douglas Edward McCann; John Galanek; John S. Goetz; Jon R. Knight; Juanita Brooks; Kelly A Del Dotto; Martin Ellison; Mary I. Akhimien; Matt Colvin; Min Woo Park; Ronald P. Golden , III; Ryan Patrick Newell; Sarah Cork; Stephanie L. Donahue; William D. Marsillo
Firms Connolly Gallagher LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-01-22 Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,…2016 29 October 2018 1:16-cv-00812 830 Patent None District Court, D. Delaware External link to document
2016-09-16 1 January 13, 2009, United States Patent No. 7,476,652 (“the ’652 Patent”), entitled “Acidic Insulin Preparations… (Infringement of U.S. Patent No. 7,476,652) 68. Plaintiffs repeat and … This is an action for patent infringement and arises under the Patent Laws of the United States,… PATENTS-IN-SUIT 11. On April 5, 2011, United States Patent No. 7,918,833 (“… Patent and Trademark Office (“PTO”). A true and correct copy of the ’833 Patent is attached as Exhibit External link to document
2017-07-17 101 Supplemental Invalidity Contentions of U.S. Patent No. 9,604,008, filed by Merck Sharp & Dohme Corp..(Connolly…2016 29 October 2018 1:16-cv-00812 830 Patent None District Court, D. Delaware External link to document
2018-01-02 180 Summary Judgment of Noninfringement of U.S. Patent Nos. 8,603,044; 8,992,486; 8,679,069; 9,526,844; 9,533,…2016 29 October 2018 1:16-cv-00812 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Merck
Baxter
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.